You are here

New Recommendations on Use of Hormone Therapy in Postmenopausal Women

Hormone treatment may increase risk of chronic diseases (Oct. 23)

The U.S. Preventive Services Task Force has released a final statement recommending against the use of hormone therapy in women who have experienced menopause to prevent chronic conditions.

Hormone therapy includes the use of estrogen and progestin in postmenopausal women and estrogen alone in postmenopausal women who have had a hysterectomy.

The Task Force recommendation does not address the use of hormone therapy for the management of menopausal symptoms, such as hot flashes.

“In the past, it was thought that taking hormones after menopause ended might reduce a woman’s risk of developing certain chronic diseases, such as heart disease or dementia,” said Task Force member Kirstin Bibbins-Domingo, PhD, MD. “However, its use in this way does not help prevent these conditions and may even increase a woman’s chance of developing them. Importantly, the use of these medications can cause serious harm to a woman’s health, such as stroke, blood clots, or gallbladder disease.”

Many major health organizations recommend against hormone therapy in postmenopausal women to prevent chronic conditions because of increased risk of serious health outcomes. These groups include the American Heart Association, the American Congress of Obstetricians and Gynecologists, and the American Academy of Family Physicians. The Task Force issued a similar recommendation in 2005. To make the updated recommendation, the Task Force commissioned a comprehensive review of the science published since that time.

“The Task Force recommends a number of important preventive measures women can take to avoid chronic diseases, including quitting smoking and identifying and treating high blood pressure and high cholesterol,” said Bibbins-Domingo.

There are also other effective ways that women can reduce their risk of bone fractures, such as weight-bearing exercise and being screened and treated, as appropriate, for osteoporosis.

The updated recommendations were published online in the Annals of Internal Medicine.

The Task Force is an independent group of national experts in prevention and evidence-based medicine who work to improve the health of Americans by making evidence-based recommendations about clinical preventive services, such as screenings, counseling services, and preventive medications.

Source: U.S. Preventive Services Task Force, October 23, 2012.

Recent Headlines

Mortality nearly doubled when patients stopped using their drugs
Acasti reports disappointing results for a second Omega-3-based drug
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
So far in January, the increases average 5%
Fast-acting insulin aspart may simplify mealtime dosing
Simple change in dosage and route may improve a century-old vaccine
Neurodevelopmental deficits detected in Colombian toddlers